Related Experiment Video
Updated: May 6, 2026

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.7K
Improving diabetes outcomes by an innovative group visit model: a pilot study
1Family Health Care Center, Statesboro, Georgia.
Journal of the American Association of Nurse Practitioners
|October 31, 2013
Summary
A new group visit model significantly improved key health markers for diabetes patients, including A1C, blood pressure, and depression. This approach shows promise for enhancing diabetes care in primary settings.
Area of Science:
- Endocrinology
- Primary Care Medicine
- Health Services Research
Background:
- Diabetes mellitus is a chronic condition requiring ongoing management.
- Effective primary care models are crucial for improving patient outcomes.
- Group visits offer a potential strategy for managing chronic diseases like diabetes.
Purpose of the Study:
- To develop and evaluate a group visit model for patients with diabetes.
- To assess the model's impact on glycemic control (A1C), blood pressure, lipids, depression, and patient satisfaction.
- To determine the feasibility of implementing this model in primary care settings.
Main Methods:
- A pre/post-test descriptive study design was employed.
- Data were collected from 22 adult patients with diabetes (A1C ≥ 7.5) in a private family practice.
- Clinical outcomes (A1C, blood pressure, weight, lipids) and patient-reported measures (depression, satisfaction) were assessed before and after the group visits.
Main Results:
- A significant mean reduction of 1.1 points in A1C was observed (p = .009).
- Mean weight decreased by 3.01 pounds (p = .001) and diastolic blood pressure improved by 5.76 mmHg (p = .002).
- Significant improvements were noted in depression scores (p = .045) and patient satisfaction (p = .028).
Conclusions:
- The group visit model demonstrated effectiveness in improving clinical outcomes for diabetes patients.
- Preliminary findings suggest this model is realistic for implementation by nurse practitioners.
- Further research is warranted to validate these promising results in broader populations.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
1.5K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K
Type II Diabetes I: Introduction
57
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
57
Diabetes Mellitus: Type 2 and Gestational
5.0K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.0K
Peripheral Artery Disease III: Interprofessional Care
659
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
659
Diabetes Mellitus: Introduction
57
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and...
57
Type I Diabetes I: Introduction
89
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1...
89
